期刊
NATURE REVIEWS IMMUNOLOGY
卷 7, 期 7, 页码 519-531出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nri2099
关键词
-
类别
资金
- NIAID NIH HHS [R01 AI064569] Funding Source: Medline
Xenotransplantation using pigs as the transplant source has the potential to resolve the severe shortage of human organ donors. Although the development of relatively non-toxic immunosuppressive or tolerance-inducing regimens will be required to justify clinical trials using pig organs, recent advances in our understanding of the biology of xenograft rejection and zoonotic infections, and the generation of alpha 1,3-galactosyltransferase-deficient pigs have moved this approach closer to clinical application. This Review highlights the major obstacles impeding the translation of xenotransplantation into clinical therapies and the potential solutions, providing a perspective on the future of clinical xenotransplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据